The i3 team and affiliated faculty at Massachusetts General Hospital and Harvard Medical School have extensive expertise in the biology and pathophysiology of common diseases, technology development, clinical trials, regulatory science, data science, medicinal chemistry, drug safety, medical device development, and entrepreneurship. Together with leading researchers and industry partners, we work to develop, clinically deploy, and commercialize novel diagnostic and therapeutic tools. Our goal is to facilitate translation of new technology into products and solutions that have an impact on healthcare.
The i3 works with groups and individuals within and outside i3 to assess needs and create a customized technology translation strategy, drawing upon the abilities of our faculty and a wide array of resources accessible to us. From state-of-the-art laboratories to novel diagnostic probes, high-tech devices, unique animal models, and first in human trials – we can help connect you with your next big step, and support you through the process.